|
New Delhi, Jan 27: Indian council of medical research (ICMR) has on Wednesday said that Bharat Biotech’s Covaxin vaccine has been proved to work against new UK COVID strain.
When the number of people identified as carrying the UK variant of Covid-19 strain in was rising in India, experiments began at the ICMR’s National Institute of Virology to assess whether Covaxin can neutralise the new strain.
Covaxin, which has been jointly developed by Bharat Biotech and the ICMR, had received the restricted emergency use authorisation by the apex drug regulator in India along with Oxford University-AstraZeneca’s Covishield, being manufactured in India by the Serum Institute of India.
The approval of…
